Free Trial
ASX:PNV

PolyNovo (PNV) Stock Price, News & Analysis

PolyNovo logo

About PolyNovo Stock (ASX:PNV)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3.38 million shs
Average Volume
N/A
Market Capitalization
$1.30 billion
P/E Ratio
247.31
Dividend Yield
6.86%
Price Target
N/A
Consensus Rating
N/A

Company Overview

PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.

Receive PNV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PolyNovo and its competitors with MarketBeat's FREE daily newsletter.

PNV Stock News Headlines

“You all just got a lot richer”
Trump Knows What He’s Doing. When the president says he’s going to let RFK “go wild” … and Big Pharma crashes. Do you think that’s an accident? When he threatens to “End the Fed” do you think he doesn’t know banking stocks will benefit? What about when he tells his followers, “Now is a good time to buy,” hours before relaxing tariffs and sending the market soaring? Is that an accident? Larry Benedict doesn’t think so. He thinks Trump knows what he’s doing… and believes he’s found the perfect tickers for everyday Americans to take advantage next time he triggers a big move.
See More Headlines

PNV Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that PolyNovo investors own include Align Technology (ALGN), Amgen (AMGN), DocuSign (DOCU), Panoramic Resources (PAN), Plug Power (PLUG) and Roku (ROKU).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:PNV
CIK
N/A
Fax
N/A
Employees
237
Year Founded
N/A

Profitability

Trailing P/E Ratio
247.31
Forward P/E Ratio
N/A
P/E Growth
2.63
Net Income
$5.26 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$103.23 million
Price / Cash Flow
207.50
Book Value
A$0.10 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$1.30 billion
Optionable
Not Optionable
Beta
1.67
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (ASX:PNV) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners